Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a.
about
MicroRNA, nutrition, and cancer preventionOld drug, new trick: repurposing metformin for gynecologic cancers?GSK-3 as potential target for therapeutic intervention in cancerHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsRepurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastomaMiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4Metformin alters DNA methylation genome-wide via the H19/SAHH axisDeregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancersMetformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells.Gerosuppressant metformin: less is moreMicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2.Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case SeriesAn evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancerMetformin: multi-faceted protection against cancer.Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bHuman liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs.Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metforminEffects of ectopic expression of NGAL on doxorubicin sensitivity.Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.Association of selected medical conditions with breast cancer risk in Korea.MicroRNA as a novel drug target for cancer therapy.Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.MicroRNAs, stem cells and cancer stem cells.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.The cancer stem cell hypothesis: a guide to potential molecular targets.Metabostemness: a new cancer hallmark.Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
P2860
Q27010206-0E976C4E-A718-4057-B3C7-D473CA7E8DFEQ27010558-76C14DE3-C923-413F-82C6-00FE6A2EB58CQ27013811-4B44AE8E-EC3C-46B6-87C8-7F4B0C7E8B69Q28393898-BFA3CC99-6AC6-478B-9A3E-E09594D5E601Q28816972-003A5232-08B0-4B07-88F2-A741E872B4B5Q31103041-5F4B9D84-CDBC-46A1-8A7A-54AA97DCD2B4Q33635268-684D099C-2001-47CE-B99F-033BE1B3F42AQ34103963-10D38432-C014-4CE8-B67D-CAA700DC2804Q34357952-40A6AF0B-EE6A-4FC5-8C6B-1A7815EBED64Q34547703-7D46E130-6435-4570-BEFD-1988CD0355F1Q35052060-06B96BF2-7C3F-4C10-B512-CBBD042A7FB2Q35098110-F08FBE65-11B3-47D9-8E13-D1374BE668E5Q35161241-2740A613-E06F-4D65-9349-E3B8F861F7C9Q35226909-22898F36-669C-4ACD-A8FA-2A38505F4B28Q35598290-544B38A9-588D-4EDA-8978-0D9B3F2053ABQ35645149-1AABED6A-A2AF-40BE-92F2-46102F5AE4A9Q35764409-45DD31E2-0A19-447D-A0EF-997E8553FD0EQ35770306-2CC15EE6-1287-4A20-9110-299FA35264F7Q35954892-13CD8D45-9EDB-4D0C-A308-1D4EE9F19A40Q36062114-B8720F2E-6D53-4A75-8CDC-00E187338C15Q36310047-C207A886-5BCC-4B0C-92B3-DD59610A02F1Q36361245-6318A258-411B-45E4-AC88-B7F04C07F4C6Q36473698-B3A2FC87-68C4-479C-BC5B-26BF96C2AE68Q36556350-BA37E7D4-7A09-40D8-B48A-1D86C7120611Q36618624-06445B3F-510B-42D5-AF09-CE27B5CC4773Q36862768-AB39F321-D627-4E77-971C-8620E1DA3D43Q36926148-C482D240-0102-458A-A168-6005D1EFECDFQ37001540-8BA2C363-876A-4F69-B217-1F41E46A1014Q37031268-0BAFA271-D692-4219-AB73-EB202BE01C1FQ37091483-CE50E063-6ABA-4146-921D-71A864CD33C1Q37118676-CFEE050B-3D23-47AB-A199-23406AC17E7FQ37205539-E6EF96ED-B379-4826-B058-38975E8D684CQ37385078-77BDBD37-8733-4DB7-AAC2-4C08ADC18C89Q37994747-80A8316C-0157-4E6E-BB2F-AB18FD75898CQ38016107-973418DA-BD9E-41B4-A3F1-DB4706EB3C79Q38044902-967C26F1-AFDC-4972-8079-BA3DFD33AA70Q38147841-5C0C5462-3B70-4FE2-8C4A-91EC593312D7Q38254181-392E0C4F-7E63-4A11-90E0-25CB8BFDB63AQ38261030-B1DA85D9-8014-4CDD-8BC0-6F65BA2DB4B1Q38309242-A7CD09B4-BD44-4E5F-8B9F-59D5F1481EA4
P2860
Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Micro
@nl
Micro(mi)RNA expression profil ...... Fβ-induced oncomiR miRNA-181a.
@en
type
label
Micro
@nl
Micro(mi)RNA expression profil ...... Fβ-induced oncomiR miRNA-181a.
@en
prefLabel
Micro
@nl
Micro(mi)RNA expression profil ...... Fβ-induced oncomiR miRNA-181a.
@en
P2093
P356
P1433
P1476
Micro(mi)RNA expression profil ...... Fβ-induced oncomiR miRNA-181a.
@en
P2093
Alejandro Vazquez-Martin
Cristina Oliveras-Ferraros
Javier A Menendez
Sonia Del Barco
Sílvia Cufí
Violeta Zenobia Torres-Garcia
P304
P356
10.4161/CC.10.7.15210
P577
2011-04-01T00:00:00Z